In addition to rash and fever, other manifestations may include lymphadenopathy, hematologic abnormalities, and internal organ involvement (most commonly liver, kidney, lung, and cardiac injury)
While the majority of side effects so far reported to the MHRA for tirzepatide and semaglutide are non-serious 22 , there are growing warnings about serious conditions, such as acute pancreatitis, associated with GLP-1 use, although studies currently remain inconclusive 25
Entre los ms recientes: Cardiostation: un viaje por la enfermedad cardiovascular (2019) (7,4 crditos CFC)
Despite the promising anecdotal reports, scientific studies supporting the effectiveness of many alternative treatments are limited and often small in scale